Year | Funding IC | FY Total Cost by IC |
---|---|---|
2023 | National Institute on Alcohol Abuse and Alcoholism | $77,996 |
2023 | National Institute of Allergy and Infectious Diseases | $1,781,384 |
2023 | National Cancer Institute | $337,957 |
2023 | National Institute on Drug Abuse | $133,373 |
2023 | National Institute of Diabetes and Digestive and Kidney Diseases | $77,996 |
2023 | Eunice Kennedy Shriver National Institute of Child Health and Human Development | $750,000 |
2023 | National Heart Lung and Blood Institute | $155,991 |
2023 | John E. Fogarty International Center for Advanced Study in the Health Sciences | $83,333 |
Year | Funding IC | FY Total Cost by IC |
---|
Funding IC | FY Total Cost by IC | NIH Spending Category |
---|---|---|
NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM | $77,996 | Alcoholism, Alcohol Use and Health; Biodefense and Related Countermeasures; Cancer; Clinical Research; Coronaviruses; Coronaviruses Disparities and At-Risk Populations; Dissemination and Implementation Research; Emerging Infectious Diseases; HIV/AIDS; Infectious Diseases; Networking and Information Technology R&D (NITRD); Pediatric; Rare Diseases; Substance Misuse; Telehealth; Tuberculosis; Women's Health |
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES | $1,594,194 | Biodefense and Related Countermeasures; Cancer; Clinical Research; Coronaviruses; Coronaviruses Disparities and At-Risk Populations; Dissemination and Implementation Research; Emerging Infectious Diseases; HIV/AIDS; Infectious Diseases; Networking and Information Technology R&D (NITRD); Pediatric; Rare Diseases; Telehealth; Tuberculosis |
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES | $187,190 | Biodefense and Related Countermeasures; Cancer; Clinical Research; Coronaviruses; Coronaviruses Disparities and At-Risk Populations; Dissemination and Implementation Research; Emerging Infectious Diseases; HIV/AIDS; Infectious Diseases; Networking and Information Technology R&D (NITRD); Pediatric; Rare Diseases; Telehealth; Tuberculosis |
NATIONAL CANCER INSTITUTE | $114,905 | Behavioral and Social Science; Prevention |
NATIONAL CANCER INSTITUTE | $168,979 | Women's Health |
NATIONAL CANCER INSTITUTE | $337,957 | Biodefense and Related Countermeasures; Cancer; Clinical Research; Coronaviruses; Coronaviruses Disparities and At-Risk Populations; Dissemination and Implementation Research; Emerging Infectious Diseases; HIV/AIDS; Infectious Diseases; Networking and Information Technology R&D (NITRD); Pediatric; Rare Diseases; Telehealth; Tuberculosis |
NATIONAL INSTITUTE ON DRUG ABUSE | $133,373 | Biodefense and Related Countermeasures; Cancer; Clinical Research; Coronaviruses; Coronaviruses Disparities and At-Risk Populations; Dissemination and Implementation Research; Drug Abuse (NIDA only); Emerging Infectious Diseases; HIV/AIDS; Infectious Diseases; Networking and Information Technology R&D (NITRD); Pediatric; Rare Diseases; Substance Misuse; Telehealth; Tuberculosis |
NATIONAL INSTITUTE ON DRUG ABUSE | $66,687 | Women's Health |
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES | $38,998 | Women's Health |
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES | $77,996 | Biodefense and Related Countermeasures; Cancer; Clinical Research; Coronaviruses; Coronaviruses Disparities and At-Risk Populations; Dissemination and Implementation Research; Emerging Infectious Diseases; HIV/AIDS; Infectious Diseases; Networking and Information Technology R&D (NITRD); Pediatric; Rare Diseases; Telehealth; Tuberculosis |
EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT | $375,000 | Behavioral and Social Science; Prevention |
EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT | $750,000 | Biodefense and Related Countermeasures; Cancer; Clinical Research; Coronaviruses; Coronaviruses Disparities and At-Risk Populations; Dissemination and Implementation Research; Emerging Infectious Diseases; HIV/AIDS; Infectious Diseases; Networking and Information Technology R&D (NITRD); Pediatric; Pediatric AIDS; Rare Diseases; Telehealth; Tuberculosis; Women's Health |
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE | $155,991 | Biodefense and Related Countermeasures; Cancer; Clinical Research; Coronaviruses; Coronaviruses Disparities and At-Risk Populations; Dissemination and Implementation Research; Emerging Infectious Diseases; HIV/AIDS; Infectious Diseases; Networking and Information Technology R&D (NITRD); Pediatric; Rare Diseases; Telehealth; Tuberculosis; Women's Health |
FOGARTY INTERNATIONAL CENTER | $41,667 | Women's Health |
FOGARTY INTERNATIONAL CENTER | $83,333 | Biodefense and Related Countermeasures; Cancer; Clinical Research; Coronaviruses; Coronaviruses Disparities and At-Risk Populations; Dissemination and Implementation Research; Emerging Infectious Diseases; HIV/AIDS; Infectious Diseases; Networking and Information Technology R&D (NITRD); Pediatric; Rare Diseases; Telehealth; Tuberculosis |